Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 5, 2010BloodOpen Access

Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group

View Full Paper
Ask AI
Bookmark
Share

Authors

KMKelly W. MaloneyWCWilliam L. CarrollACAndrew J. Carroll

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Maloney et al. (2010) studied this question.

synapsesocial.com/papers/6aaa1f04207060c46bfbc3e3https://doi.org/10.1182/blood-2009-07-235291
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.1996 · 922 citations
  2. 2Acute lymphoblastic leukemia and Down syndrome2008 · 59 citations
  3. 3Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group2009 · 347 citations
  4. 4The Management of Neoplastic Disorders of Haematopoeisis in Children with Down's Syndrome2000 · 229 citations
  5. 5Prognosis of Down's syndrome with acute leukaemia.1990 · 91 citations